Observational studyMedicine2026
Safety analysis of acyclovir use in neonates based on the FDA Adverse Event Reporting System: A retrospective observational pharmacovigilance study.
Longbing He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.